Last reviewed · How we verify
Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate in Healthy Male Volunteers. (CCA)
This study is designated to evaluate the pharmacokinetic interactions of candesartan cilexetil and amlodipine besylate in healthy male volunteers.
Details
| Lead sponsor | HK inno.N Corporation |
|---|---|
| Phase | Phase 1 |
| Status | UNKNOWN |
| Enrolment | 40 |
| Start date | 2013-04 |
| Completion | 2013-08 |
Conditions
- Healthy
Interventions
- candesartan cilexetil 32mg, amlodipine 10mg
- candesartan cilexetil 32mg, amlodipine 10mg
Primary outcomes
- Assessment of the drug-drug interactions of candesartan and amlodipine — 10 days